Article
Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics Analysis
1 Jan 2025
Abstract excerpt
Purpose: Interleukin-6 (IL-6) is a central factor linking inflammation to cancer. This study aimed to provide a comprehensive assessment of the prognostic value of IL-6 and its immunotherapeutic features using a population-based pan-cancer analysis and comprehensive bioinformatic analysis. Patients and Methods: In the cohort study, 540 patients were included to explore the prognostic value of serum IL-6 levels in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
